RSV also accounts for about 2.1 million U.S. outpatient visits among children younger than 5 years old. To eat or not to eat:We tried Taco Bell's new chicken nuggets. Here's our (honest) review of the ...

By drawing attention to the broader impact among varied populations, we want to see more done to reveal the hidden burden that is RSV. Regulators have started reviews of GSK's depemokimab ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

RSV is responsible for over 33 million lung infections ... The Guardian, MIT Technology Review, and others.

Emergency visits related to the flu and RSV remain high and very high in the ... The Florida Department of Health’s Jan. 4 flu review showed that flu positivity rate and emergency room visits ...

Concerns about GBS arose during the review of safety data from clinical ... of lower respiratory tract disease (LRTD) associated with RSV in adults aged 60 years or more, and has since been ...

New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly ...

“This trial reinforces our confidence in our RSV vaccine’s ability to help protect ... “We will submit [this] data for regulatory review as quickly as possible, with the goal of offering ...

Community wastewater surveillance as of Jan. 8 shows moderate concentrations of the virus that causes COVID-19 and high concentrations of RSV and influenza A in Clark County, the release said.